SCHEMBL8735550

SCHEMBL8735550

Cc1ccccc1C(=O)CC(=O)c1ccccc1C

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.74
FEN1 P39748 1/20 0.74
NPC1 O15118 2/20 0.60
KMT2A Q03164 2/20 0.60
MEN1 O00255 1/20 0.60
RAB9A P51151 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
HPGD P15428 3/20 0.53
CTNNB1 P35222 3/20 0.53
WNT3A P56704 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.47
POLB P06746 1/20 0.47
TYK2 P29597 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL269381 0.90 ERCC5 (0.68) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL29483365 0.90 ERCC5 (0.68) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL3660192 0.89 ERCC5 (0.72) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL8383887 0.89 ERCC5 (0.67) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL17867035 0.87 ERCC5 (0.65) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL30089517 0.86 CTNNB1 (0.68) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL15979740 0.86 CTNNB1 (0.68) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL3166061 0.86 ERCC5 (0.62) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL13684611 0.86 ERCC5 (0.62) ERCC5FEN1NPC1KMT2AMEN1
SCHEMBL8348768 0.84 ERCC5 (0.61) ERCC5FEN1NPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0614916-B1 Process for producing polyolefin IDEMITSU PETROCHEMICAL CO (JP) 1998-10-07 EP claimed
US-5605990-A USING CATALYST COMPRISING TITANIUM COMPOUND, ALUMINOXANE, AROMATIC RING-CONTAINING COMPOUND IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1997-02-25 US claimed
EP-0614916-A1 Process for producing polyolefin IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1994-09-14 EP claimed
CN-110143935-B Preparation method of 2, 5-disubstituted furan derivative 华侨大学 2022-09-30 CN disclosed
CN-115093323-A Beta-functionalized chiral homoallyl alcohol derivative and preparation method and application thereof 武汉大学 2022-09-23 CN disclosed
CN-107126660-B Composition containing fluoroketone 中化蓝天集团有限公司 2021-02-05 CN disclosed
EP-3122735-B1 3-PHENYL-7-HYDROXY-ISOCOUMARINS AS MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) INHIBITORS THE PROVOST FELLOWS FOUND SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIV (IE) 2019-05-08 EP disclosed
US-20190071410-A1 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2019-03-07 US disclosed
US-20170144983-A1 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2017-05-25 US disclosed
US-20170144983-A1 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2017-05-25 US disclosed
US-9371422-B2 Titanium containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts DOW CORNING CORPORATION (US) 2016-06-21 US disclosed
US-20140213690-A1 Titanium Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts DOW CORNING CORPORATION (US) 2014-07-31 US disclosed
WO-2013036546-A2 TITANIUM CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2013-03-14 WO disclosed
EP-0614916-B1 Process for producing polyolefin IDEMITSU PETROCHEMICAL CO (JP) 1998-10-07 EP disclosed
US-5605990-A USING CATALYST COMPRISING TITANIUM COMPOUND, ALUMINOXANE, AROMATIC RING-CONTAINING COMPOUND IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1997-02-25 US disclosed
EP-0614916-A1 Process for producing polyolefin IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1994-09-14 EP disclosed
EP-0598134-A1 PROCESS FOR PRODUCING POLYOLEFIN IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-05-25 EP disclosed
EP-0362012-B1 Stabiliser compositions for halogenated polymers containing beta-diketone, hydrotalcite and dihydropyridine, and polymers stabilized therewith ATOCHEM ELF SA (FR) 1993-12-29 EP disclosed
EP-0362012-A1 Stabiliser compositions for halogenated polymers containing beta-diketone, hydrotalcite and dihydropyridine, and polymers stabilized therewith ELF ATOCHEM S.A. (FR) 1990-04-04 EP disclosed
US-4036605-A CATALYZING OXIDATION OF HYDROCARBONS WITH A B-KETOENOLATE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170144983-A1 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors MIF, CCL2, MMP12 ERCC5 3229/4885FEN1 2564/4885NPC1 184/4885
US-20190071410-A1 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors MIF, CCL2, MMP12 ERCC5 3229/4885FEN1 2564/4885NPC1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.